The hard chamber versus soft chamber question gets asked daily by patients, clinics, and home buyers. Marketing collapses the two into a single category.
The clinical reality is that they are different products. Different FDA class, different pressure, different evidence.
This guide breaks down the real differences across five dimensions:
- Pressure ratings
- FDA clearance class
- What each chamber is cleared to do
- What the published trials actually used
- Safety profile
The goal is to help you spend money where the evidence supports it — and avoid paying hard-chamber prices for soft-chamber physics.
The pressure gap is the whole story
Hard-shell hyperbaric chambers operate at 2.0 to 3.0 atmospheres absolute (ATA). The clinical sweet spot for most non-emergency indications is 2.0 to 2.4 ATA. Soft-shell chambers cap at 1.3 ATA by FDA clearance.
That gap matters because the gas physics matters. A patient breathing 100% oxygen at 2.4 ATA reaches an arterial oxygen tension of roughly 1,500 mmHg. At 1.3 ATA breathing room air, that number is about 130 mmHg — barely above normal sea-level baseline of 100 mmHg, per Tibbles & Edelsberg 1996 in NEJM.
The arterial oxygen difference between hard-chamber HBOT and soft-chamber mild HBOT is more than tenfold. That is not a marketing distinction. It is the central reason almost every FDA-approved indication was studied at hard-chamber pressures, not soft.
FDA classification and clearance
The FDA splits hyperbaric chambers into two device classes, each with its own clearance pathway through the 510(k) database.
Hard chambers are FDA Class A medical devices. Major builders include Sechrist Industries, Perry Baromedical, ETC Biomedical, and Healing Chambers International. Each holds 510(k) clearances for the 14 UHMS-recognized uses.
These chambers go into hospitals, wound clinics, and specialty HBOT centers. Sale is restricted to medical facilities.
Soft chambers are FDA Class C devices cleared for one indication: acute mountain sickness. OxyHealth, Newtowne Hyperbarics, and Summit to Sea hold consumer 510(k) clearances under this single indication.
The chambers can be sold direct to consumers. Off-label uses — recovery, anti-aging, wellness — are legal but not FDA-cleared.
The class difference is more than paperwork. Hard chambers must meet NFPA 99 standards for construction, fire safety, and emergency systems. Soft chambers operate under looser consumer-device requirements because the lower pressure carries lower risk.
What hard chambers do
Hard chambers run the protocols that built the FDA-approved list. The UHMS-recognized indications include 14 conditions:
- Decompression sickness
- Carbon monoxide poisoning
- Gas gangrene (clostridial myositis)
- Crush injury and acute traumatic ischemia
- Diabetic foot ulcers (chronic wound)
- Chronic refractory osteomyelitis
- Delayed radiation injury
- Compromised skin grafts and flaps
- Acute thermal burn injury
- Idiopathic sudden sensorineural hearing loss
- Air or gas embolism
- Severe anemia (where transfusion impossible)
- Intracranial abscess
- Necrotizing soft tissue infections
The clinical trials behind every one of these indications used hard-chamber protocols at 2.0 to 3.0 ATA. The 2015 Cochrane review on diabetic wounds used 2.0 to 2.4 ATA across the included trials. The 2018 Eskes review on osteomyelitis used 2.4 ATA. See the osteomyelitis evidence atlas for the full study-by-study evidence breakdown.
Medicare covers HBOT for the conditions on this list under National Coverage Determination 20.29. The CMS facility-side reimbursement under HCPCS code G0277 runs roughly $109 to $250 per session in 2026, depending on region. Private insurance generally mirrors the list.
What soft chambers do
Soft chambers do one FDA-cleared thing well — reverse acute mountain sickness at 1.3 ATA. That use case is documented and supported by altitude-medicine literature.
Beyond that single indication, the evidence is thin. Almost every off-label claim made for soft chambers cites studies done at hard-chamber pressures.
Take autism. The Rossignol 2009 trial in BMC Pediatrics at 1.3 ATA showed modest behavioral changes. The follow-up Granpeesheh 2010 trial in Research in Autism Spectrum Disorders at the same pressure found no benefit over sham.
A 2016 systematic review concluded the soft-chamber evidence does not support clinical use.
Anti-aging is similar. The widely cited Hachmo 2020 telomere study at Tel Aviv University used 2.0 ATA hard-chamber protocol — not soft. The same applies to the Efrati long COVID studies and to most TBI research that gets cited in soft-chamber marketing. See detailed Shamir long-COVID RCT analysis for the full Shamir-RCT methodology analysis.
The mismatch is consistent. Marketing claims about soft chambers tend to reference research done in hard chambers. Buyers should match the chamber to the evidence base.
Pressure ratings side by side
| Spec | Hard chamber | Soft chamber |
|---|---|---|
| Pressure range | 2.0–3.0 ATA | 1.3 ATA max |
| Oxygen delivery | 100% O2 via mask/hood | Room air or supplemental O2 via concentrator |
| Arterial pO2 at session | ~1,500 mmHg | ~130 mmHg |
| FDA class | Class A medical | Class C consumer |
| FDA-cleared indications | 14 UHMS conditions | Acute mountain sickness only |
| Setting | Hospital, wound center, HBOT clinic | Home or wellness studio |
| Per-session cost | $109–$500 (covered by Medicare for approved use) | One-time chamber purchase $9K–$25K |
| Insurance coverage | Yes, for approved indications | No (off-label) |
Safety profile
Both chamber types carry real risks. The risk profile shifts with pressure.
Hard chambers carry higher absolute risk per session. Higher pressure increases the chance of barotrauma and oxygen toxicity.
Middle ear barotrauma rates run 2% to 10% per the Camporesi 2014 review in Undersea & Hyperbaric Medicine. Central nervous system oxygen toxicity seizures occur roughly 1 to 4 per 10,000 sessions at 2.4 ATA. Fire risk is real but managed by NFPA 99 protocols.
The 1997 Milan chamber fire killed 11 people inside a hard chamber. It is the benchmark incident for hard-chamber fire safety.
Reputable operators follow strict rules:
- No synthetic clothing inside
- No electronics
- Pre-breathing protocols on 100% O2
- Exhaust scrubbing on every cycle
Soft chambers carry lower per-session risk because lower pressure means less barotrauma exposure. But the user error margin is much smaller. Most published soft-chamber adverse events involve oxygen leakage, fire from electronics inside the chamber, or improper pressure protocols, per a 2014 review in Undersea & Hyperbaric Medicine.
A 2025 Michigan soft-chamber fire and a string of home injuries show what happens when these units run without trained staff. Hospital settings build that training in.
Where each chamber fits
Use a hard chamber when:
- Your condition is on the UHMS-recognized list
- Insurance covers your treatment
- Your provider has UHMS-accredited facilities and CHT-certified staff
- You need 2.0+ ATA pressure per the clinical evidence
Use a soft chamber when:
- You want supplemental oxygen at altitude (mountain sickness)
- You are using it off-label with realistic expectations about the 1.3 ATA evidence base
- You understand it is not equivalent to hospital HBOT
- You can follow strict fire and electronics safety practices
Avoid either when:
- You have an untreated pneumothorax
- You have a recent ear surgery without ENT clearance
- A provider promises off-label miracles backed only by hard-chamber studies
UHMS accreditation gap
Roughly 180 of the 1,588 HBOT centers tracked in the US have UHMS accreditation — about 11%. The other 89% may still operate to high standards. Many do not.
UHMS-accredited clinics meet four requirements:
- A medical director trained in hyperbaric medicine
- CHT or CHRN-certified technicians
- Documented emergency and fire protocols
- Annual chamber inspections by qualified third parties
For hard-chamber HBOT, UHMS accreditation is the most reliable signal of a credible operation. Soft-chamber wellness centers are not eligible. UHMS scopes only to medical-grade hard-chamber care.
Restore Hyper Wellness and similar mild-HBOT chains are not UHMS-accredited because their soft-chamber wellness model falls outside the UHMS clinical-care scope. That does not make them unsafe. It does mean accreditation is not a useful signal for them.
Pricing reality in 2026
Hard-chamber sessions at private clinics typically run $200 to $500 out of pocket. Insurance covers approved indications with copay only.
Hospital wound centers billing Medicare for approved use see facility reimbursement around $109 to $250 per session. Forty-session packages at private clinics range $7,500 to $20,000.
Soft chambers for home use price between $9,500 (Newtowne Hyperbarics Solace 210) and $20,000 (OxyHealth Vitaeris 320). Summit to Sea Respiro 270 sits in the middle around $12,500. Add $1,000 to $2,500 for an oxygen concentrator if one is not bundled.
Aviv Clinics in Florida sells protocol packages built around Perry Baromedical hard chambers. Pricing typically runs $40,000 to $50,000+ for a 60-session program based on the Efrati protocol. The packages are anchored to a single 2020 study of 35 patients — substantial extrapolation from a small, unreplicated trial.
Related reading
- HBOT pressure explained: 1.3 vs 2.0 vs 2.4 ATA
- UHMS facility accreditation: what it signals to patients
- HBOT cost in 2026: insurance, out-of-pocket, home chambers
- Soft-shell HBOT chambers under $10,000 compared
Frequently asked questions
Can a soft chamber treat the same conditions as a hard chamber?
No. The pressure gap is more than tenfold in arterial oxygen tension, which is what drives the clinical effects of HBOT. Soft chambers at 1.3 ATA were not used in the trials that produced any of the 14 FDA-approved indications. Soft-chamber clinical use is FDA-cleared only for acute mountain sickness.
Is soft-chamber therapy a scam?
Not inherently. For its FDA-cleared use — reversing acute mountain sickness — it works. For off-label uses, the marketing often overstates evidence by citing hard-chamber studies. The chamber itself is legitimate hardware. The off-label claims around it often are not.
Does insurance cover either kind of HBOT?
Insurance covers hard-chamber HBOT for the 14 UHMS-recognized indications under Medicare NCD 20.29. Private insurers generally follow Medicare's list. Insurance does not cover soft chambers for any use, and does not cover off-label use of hard chambers either. Out-of-pocket pricing is the only path for any non-approved indication.
Are hard chambers safer than soft chambers?
Both are safe when used right. Hard chambers carry higher absolute risk per session due to the higher pressure. They are also run in UHMS-accredited sites with trained staff.
Soft chambers carry lower per-session risk but more user error exposure. Fire risk from electronics inside is the main concern. Per-session safety is similar when both are run to professional standards.
Can I buy a hard chamber for home use?
In practice, no. Class A medical hard chambers are sold only to medical facilities. Used hard chambers occasionally appear on the secondary market, but operating one safely requires NFPA 99 compliance, trained technicians, regular inspection, and a medical director. Home operators almost never meet these requirements. Soft chambers are the only practical home option, and they cap at 1.3 ATA.
Medical disclaimer
This article is for informational purposes only and is not a substitute for professional medical advice. Hyperbaric oxygen therapy is investigational for most off-label uses discussed here. Consult your doctor before starting any HBOT protocol, especially if you have pre-existing ear, lung, or cardiovascular conditions. Always verify a clinic's FDA-cleared use, UHMS accreditation status, and medical director credentials before booking.
-- The HBOT Finder Team